Business

Coya Therapeutics to Present at the iAccess Alpha Virtual Best Ideas Summer Conference on June 24 – 25, 2025

HOUSTON, June 18, 2025--Coya Therapeutics, Inc. (NASDAQ: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) function, announces that Chief Executive Officer Arun Swaminathan, Ph.D. will present at the iAccess Alpha Virtual Best Ideas Summer Conference on Tuesday, June 24, 2025.

articleCoya Therapeutics, Inc.June 18, 20255/company/coya-therapeutics-inc-common-stock/news/coya-therapeutics-present-iaccess-alpha-121500786
Coya Therapeutics to Present at the iAccess Alpha Virtual Best Ideas Summer Conference on June 24 – 25, 2025

About this update from Coya Therapeutics, Inc.

[{"type":"text","content":"HOUSTON, June 18, 2025--(BUSINESS WIRE)--Coya Therapeutics, Inc. (NASDAQ: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) function, announces that Chief Executive Officer Arun Swaminathan, Ph.D. will present at the iAccess Alpha Virtual Best Ideas Summer Conference on Tuesday, June 24, 2025.","length":402,"tagName":"p"},{"type":"table","headerItems":[],"items":[{"val":[{"colspan":"1","rowspan":"1","style":"margin-bottom:10.0px;margin-left:0px;margin-right:auto;width:8%;","val":[{"type":"text","content":"Event:","length":6,"tagName":"p","attribs":{}}]},{"colspan":"1","rowspan":"1","style":"vertical-align:top;padding-left:0.0px;width:92%;","val":[{"type":"text","content":"iAccess Alpha Virtual Best Ideas Summer Conference","length":50,"tagName":"p","attribs":{}}]}]},{"val":[{"colspan":"1","rowspan":"1","style":"margin-bottom:10.0px;margin-left:0px;margin-right:auto;width:8%;","val":[{"type":"text","content":"Date:","length":5,"tagName":"p","attribs":{}}]},{"colspan":"1","rowspan":"1","style":"vertical-align:top;padding-left:0.0px;width:92%;","val":[{"type":"text","content":"June 24, 2025","length":13,"tagName":"p","attribs":{}}]}]},{"val":[{"colspan":"1","rowspan":"1","style":"margin-bottom:10.0px;margin-left:0px;margin-right:auto;width:8%;","val":[{"type":"text","content":"Time:","length":5,"tagName":"p","attribs":{}}]},{"colspan":"1","rowspan":"1","style":"vertical-align:top;padding-left:0.0px;width:92%;","val":[{"type":"text","content":"10:30am ET (presentation)","length":25,"tagName":"p","attribs":{}}]}]},{"val":[{"colspan":"1","rowspan":"1","style":"margin-bottom:10.0px;margin-left:0px;margin-right:auto;width:8%;","val":[{"type":"text","content":"Webcast:","length":8,"tagName":"p","attribs":{}}]},{"colspan":"1","rowspan":"1","style":"vertical-align:top;padding-left:0.0px;width:92%;","val":[{"type":"text","content":"https://www.webcaster4.com/Webcast/Page/3118/52505","length":50,"tagName":"p","attribs":{}}]}]}],"length":163},{"type":"text","content":"Dr. Swaminathan and Chief Financial Officer David Snyder will be meeting with investors on Wednesday, June 25, 2025. For more information about the iAccess Alpha Virtual Best Ideas Summer Investment Conference 2025, or to register and schedule a one-on-one meeting with man...

More updates from Coya Therapeutics, Inc.

Coya Therapeutics, Inc.Forward-Looking StatementsSummer Conferenceproduct candidatesregulatory T cellclinical trialsDavid SnyderCoya Therapeutics, IncCoya Therapeuticsproduct candidate